CELC Celcuity Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
14:02
Jul 17
Jul 17
07:29
Jan 26
Jan 26
Celcuity remains an inexpensive biotech opportunity
The author lists Celcuity as a good biotech that remains inexpensive. He expects the biotech bull market to continue despite possible pullbacks and favors staying long or buying well-executing biotechs more aggressively. He supplies no additional Celcuity-specific rationale and discloses no personal position.
About CELC Investor Commentary
Across the available history and selected sources, Buzzberg tracks CELC (Celcuity Inc.) across 4 sources: 1 bullish vs 1 bearish calls from 4 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 16 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Mark Minervini, seedy19tron.